Emulate Stock
Emulate, Inc. is a private company focused on commercializing Organs-on-Chips.
About Emulate Stock
Emulate, Inc. is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products.
Investors
NanoDimension
Funding History
| July 2014 | $12.0M |
|---|---|
| March 2016 | $28.0M |
| October 2016 | $17.0M |
| June 2017 | $2.0M |
| June 2018 | $36.0M |
Management
Co-Founder and CSO
Geraldine A. Hamilton
Co-Founder and CEO
James Coon
Co-Founder and Chief Technology Officer
Daniel Levner
Press
EPM Magazine - Jun, 22 2018
BioPharma Dive - Jun, 21 2018
- Mar, 28 2016
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Emulate or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
